Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics | HappeningNow.news
Published Date: June 07, 2026

Business & Economy

Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics

Novo itself is beginning to generate data suggesting semaglutide may actually affect biological processes linked to aging, not just body weight.

Source Fortune Updated 2h 21m ago AI Summary

AI Summary

Novo itself is beginning to generate data suggesting semaglutide may actually affect biological processes linked to aging, not just body weight.

Read full article on Fortune

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence
SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow